SCHEMBL7186586

SCHEMBL7186586

COC(=O)C(=O)CC(=O)c1ccn(Cc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 1/20 0.44
CYP2C19 P33261 1/20 0.44
AKR1B1 P15121 1/20 0.39
PTPN1 P18031 2/20 0.38
ERCC5 P28715 2/20 0.38
FEN1 P39748 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
APP P05067 1/20 0.37
SNCA P37840 1/20 0.37
BRD4 O60885 1/20 0.36
BRD2 P25440 1/20 0.36
BRD3 Q15059 1/20 0.36
BRDT Q58F21 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7184197 0.86 FEN1 (0.54) KLKB1CYP2C19AKR1B1PTPN1ERCC5
SCHEMBL10590280 0.81 TSHR (0.50) KLKB1CYP2C19AKR1B1CA1CA2
SCHEMBL7189635 0.79 ERCC5 (0.50) ERCC5FEN1CDK5CDK5R1KMT2A
SCHEMBL10296127 0.78 MAPT (0.53) KLKB1CYP2C19AKR1B1CA12CA1
SCHEMBL7191520 0.77 ERCC5 (0.43) KLKB1PTPN1ERCC5FEN1KMT2A
SCHEMBL4670870 0.76 CYP2C19 (0.53) KLKB1CYP2C19AKR1B1CA12CA1
SCHEMBL2514239 0.76 CYP2C19 (0.55) KLKB1CYP2C19AKR1B1CA12CA1
SCHEMBL1109662 0.76 ERCC5 (0.64) CYP2C19PTPN1ERCC5FEN1CYP1A2
SCHEMBL7190675 0.75 ALDH1A1 (0.43) KLKB1PTPN1ERCC5FEN1KMT2A
SCHEMBL7191455 0.75 FEN1 (0.58) PTPN1ERCC5FEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP claimed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed